Clinical Trial Update: Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early allogeneic blood stem cell transplantation in high-risk acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED